The US House of Representatives passed a stem cell research bill earlier this month as part of the new Democratic leadership's initial round of legislation. The proposal would largely undo President Bush's restrictions on the federal funding of human embryonic stem cell research, but is expected to meet the same fate it did in the previous session of Congress: a veto by the President, and a failure by Congress to override that veto.
The Center for Genetics and Society issued a press statement urging the President to reconsider his position, but also noting that the lack of federal oversight of stem cell research poses a challenge for its supporters. The Seattle Post-Intelligencer published an op-ed by CGS's Osagie K. Obasogie and Parita Shah highlighting the "polarization and simplification" of the stem cell debate.
Finally, the liberal political strategy group The Third Way released a memo, The Responsible Path Forward on Stem Cell Research: Supporting DeGette-Castle while Avoiding the Traps, that includes a six-page appendix by CGS titled Federal Stem Cell Policy: Lessons from California.
Meanwhile, the new Democratic governor of New York has proposed that his state invest one to two billion dollars in stem cell research.